3.0
FAP: In vitro induction of adipogenesis
Pathway ID: SIGNOR-FAPadipo
Description: This pathway consists of the integration of three pathways: "insulin receptor (INSR)", "glucocorticoids" and "IBMX/rosiglitazone". It focuses on the causal relations occurring between the canonical inducers of adipogenesis used in in-vitro experiments. This pathway integrates and compares data from experiments performed on primary cells or with non-canonical stimuli.
Curated by: Marco Rosina
Description: This pathway consists of the integration of three pathways: "insulin receptor (INSR)", "glucocorticoids" and "IBMX/rosiglitazone". It focuses on the causal relations occurring between the canonical inducers of adipogenesis used in in-vitro experiments. This pathway integrates and compares data from experiments performed on primary cells or with non-canonical stimuli.
Curated by: Marco Rosina
26 Seed Entities
Organism: 
|
Name | Primary ID |
|---|---|
| DLK1 | P80370 |
| PDE1C | Q14123 |
| PDE1B | Q01064 |
| GATA2 | P23769 |
| dexamethasone | CHEBI:41879 |
| PI3K | SIGNOR-C156 |
| PDE1A | P54750 |
| PDPK1 | O15530 |
| PRKACA | P17612 |
| NR3C1 | P04150 |
| CREB1 | P16220 |
| rosiglitazone | CHEBI:50122 |
| PPARG | P37231 |
| ADCY1 | Q08828 |
| PIP3 | CHEBI:16618 |
| INSR | P06213 |
| HES1 | Q14469 |
| FOXA2 | Q9Y261 |
| INS | P01308 |
| HDAC1 | Q13547 |
| 3',5'-cyclic AMP | CHEBI:17489 |
| 3-isobutyl-1-methyl-7H-xanthine | CHEBI:34795 |
| Adipogenesis | SIGNOR-PH26 |
| AKT | SIGNOR-PF24 |
| CEBPB | P17676 |
| FOXO1 | Q12778 |